and leukemia: clinical value of their detection by immunocytochemistry Proteins encoded by genes involved in chromosomal alterations in lymphoma
暂无分享,去创建一个
[1] 刘金明,et al. IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .
[2] B. Falini. Anaplastic large cell lymphoma: pathological, molecular and clinical features , 2001 .
[3] L. Meltesen,et al. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion. , 2001, Blood.
[4] M. Shimizu,et al. Anaplastic Lymphoma Kinase Expression in Inflammatory Pseudotumors , 2001, The American journal of surgical pathology.
[5] P. Marynen,et al. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. , 2001, The American journal of pathology.
[6] H. Kosaka,et al. l-Arginine improves endothelial function in renal artery of hypertensive Dahl rats , 2001, Journal of hypertension.
[7] S. Pileri,et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. , 2000, Blood.
[8] E. Vichinsky,et al. Patterns of Arginine and Nitric Oxide in Patients With Sickle Cell Disease With Vaso-occlusive Crisis and Acute Chest Syndrome , 2000, Journal of pediatric hematology/oncology.
[9] J. Esteve,et al. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3. , 2000, American journal of clinical pathology.
[10] B. Falini,et al. Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma. , 2000, Blood.
[11] F. Birg,et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Mole , 2000, Blood.
[12] M. Ladanyi. Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms. , 2000, The American journal of pathology.
[13] P. D. Dal Cin,et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.
[14] R. Nagel,et al. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. , 2000, American journal of physiology. Heart and circulatory physiology.
[15] E. Kang,et al. Normal circulating adult human red blood cells contain inactive NOS proteins. , 2000, The Journal of laboratory and clinical medicine.
[16] K. Pulford,et al. Expression of the ALK tyrosine kinase gene in neuroblastoma. , 2000, The American journal of pathology.
[17] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[18] E. Campo,et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. , 1999, Blood.
[19] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[20] C. Brugnara,et al. Endothelins activate Ca2+-gated K+ channels via endothelin B receptors in CD-1 mouse erythrocytes. , 1999, American journal of physiology. Cell physiology.
[21] B. Falini,et al. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. , 1999, Blood.
[22] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Marynen,et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. , 1999, Blood.
[24] T. Greiner,et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. , 1999, Blood.
[25] S. Pileri,et al. ALK+ lymphoma: clinico-pathological findings and outcome. , 1999, Blood.
[26] G. Delsol,et al. Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases , 1999, British journal of haematology.
[27] J. Licht,et al. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia , 1999, Oncogene.
[28] B Falini,et al. Detection of normal and chimeric nucleophosmin in human cells. , 1999, Blood.
[29] R. Nagel,et al. Two distinct pathways mediate the formation of intermediate density cells and hyperdense cells from normal density sickle red blood cells. , 1998, Blood.
[30] L. Trümper,et al. Detection of the t(2;5)‐associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals , 1998, British journal of haematology.
[31] R. Nagel,et al. Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. , 1998, Kidney international.
[32] S. Pileri,et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. , 1998, The American journal of pathology.
[33] J. Chan,et al. Anaplastic Large Cell Lymphoma: Redefining Its Morphologic Spectrum and Importance of Recognition of the ALK‐Positive Subset , 1998, Advances in anatomic pathology.
[34] J. Mehta,et al. Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. , 1998, Journal of cardiovascular pharmacology.
[35] S. Higano,et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. , 1998, Circulation.
[36] H. Fathallah,et al. Deoxygenation of sickle red blood cells stimulates KCl cotransport without affecting Na+/H+ exchange. , 1998, The American journal of physiology.
[37] P. Pelicci,et al. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies , 1998, Oncogene.
[38] S. Pileri,et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. , 1998, Blood.
[39] K. Pulford,et al. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. , 1998, Cancer research.
[40] T. Sternsdorf,et al. Evidence for Covalent Modification of the Nuclear Dot–associated Proteins PML and Sp100 by PIC1/SUMO-1 , 1997, The Journal of cell biology.
[41] P. Freemont,et al. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. , 1997, Blood.
[42] M. Seto,et al. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. , 1997, The American journal of surgical pathology.
[43] G. Morgan,et al. The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody , 1997, British journal of haematology.
[44] S. Pileri,et al. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). , 1997, Blood.
[45] H. Herbst,et al. Absence of anaplastic lymphoma kinase (ALK) and Epstein–Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis , 1997, The British journal of dermatology.
[46] R. Nagel,et al. Red Blood Cells of a Transgenic Mouse Expressing High Levels of Human Hemoglobin S Exhibit Deoxy-stimulated Cation Flux , 1997, The Journal of Membrane Biology.
[47] J M Davies,et al. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Wells,et al. Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia , 1997, Nature Genetics.
[49] S. Lessin,et al. The pathogenesis of large cell transformation in cutaneous T‐cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation , 1997, Journal of cutaneous pathology.
[50] J. Guillet,et al. Peptides derived from the whole sequence of BCR‐ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes , 1997, European journal of immunology.
[51] E. Campo,et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. , 1997, The American journal of pathology.
[52] J. Zweier,et al. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Hudetz,et al. Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. , 1997, Blood.
[54] R. Nagel,et al. K:CI cotransport in red cells of transgenic mice expressing high levels of human hemoglobin S , 1997, American journal of hematology.
[55] V. Lew,et al. Stochastic nature and red cell population distribution of the sickling-induced Ca2+ permeability. , 1997, The Journal of clinical investigation.
[56] C. Naeve,et al. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) , 1997, Oncogene.
[57] Wei Tang,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.
[58] M. Cleary,et al. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. , 1997, Blood.
[59] F. Behm,et al. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility. , 1997, Blood.
[60] S. Pileri,et al. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. , 1997, The American journal of pathology.
[61] K. Pulford,et al. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis , 1997, Molecular and cellular biology.
[62] P. Brousset,et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. , 1997, Blood.
[63] K. Pulford,et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. , 1997, Blood.
[64] E. Jaffe,et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. , 1997, Blood.
[65] C. Melief,et al. Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. , 1996, Blood.
[66] R. Nagel,et al. Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: the effect of hypoxia. , 1996, Blood.
[67] H. Kantarjian,et al. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients. , 1996, American journal of clinical pathology.
[68] G. Pawelec,et al. BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. , 1996, Blood.
[69] C. Peschle,et al. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. , 1996, The EMBO journal.
[70] S. Mori,et al. The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK. , 1996, Leukemia & lymphoma.
[71] R. Rousset,et al. Exclusion of Int-6 from PML Nuclear Bodies by Binding to the HTLV-I Tax Oncoprotein , 1996, Science.
[72] S. Snyder,et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[73] T. Rector,et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. , 1996, Circulation.
[74] R. Nagel,et al. Renal nitric oxide synthases in transgenic sickle cell mice. , 1996, Kidney international.
[75] A. Sette,et al. Specific human cellular immunity to bcr-abl oncogene-derived peptides. , 1996, Blood.
[76] H. Satoh,et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[77] M. Kadin,et al. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. , 1996, Blood.
[78] S. Corey,et al. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. , 1996, Blood.
[79] S. Pittaluga,et al. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. , 1996, Blood.
[80] S. Raimondi,et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.
[81] N. Sacchi,et al. Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia. , 1996, Oncogene.
[82] J. Licht,et al. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. , 1996, Oncogene.
[83] R. Krumlauf,et al. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. , 1995, Blood.
[84] W. Chan,et al. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. , 1995, Blood.
[85] E. Schuuring,et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. , 1995, Blood.
[86] E. Jaffe,et al. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. , 1995, Blood.
[87] S. Mori,et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. , 1995, Leukemia.
[88] H. Ginsburg,et al. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor , 1995, The Journal of experimental medicine.
[89] H. Stein,et al. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. , 1995, Blood.
[90] M. V. van Dijk,et al. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells. , 1995, Leukemia.
[91] R. Evans,et al. Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha protein , 1995 .
[92] J. Downing,et al. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. , 1995, Blood.
[93] N. Harris,et al. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. , 1995, American journal of clinical pathology.
[94] S. J. Holt,et al. Ligand-induced translocation of epidermal growth factor receptor to the nucleus of NR6/HER fibroblasts is serum dependent. , 1995, Experimental cell research.
[95] J. Licht,et al. Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[96] H. Frierson,et al. Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. , 1995, The American journal of pathology.
[97] H. Satoh,et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. , 1994, Blood.
[98] D. Catovsky,et al. Differential expression of c-myc protein in B and T lymphocytes. , 1994, Leukemia.
[99] N. Zegers,et al. Recognition of the ALL-specific BCR-ABL junction in P190bcr-abl by monoclonal antibody ER-FP1. , 1994, Leukemia.
[100] A. Deisseroth,et al. BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. , 1994, Blood.
[101] H. Satoh,et al. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. , 1994, Oncogene.
[102] S. Alper,et al. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. , 1994, The Journal of clinical investigation.
[103] D N Shapiro,et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.
[104] S. J. Holt,et al. Epidermal growth factor induced tyrosine phosphorylation of nuclear proteins associated with translocation of epidermal growth factor receptor into the nucleus. , 1994, Biochemical pharmacology.
[105] R. Kurzrock,et al. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. , 1993, The Journal of clinical investigation.
[106] J. Whitlock,et al. A Small‐Cell‐Predominant Variant of Primary Ki‐1 (CD30)+ T‐Cell Lymphoma , 1993, The American journal of surgical pathology.
[107] A. Zelent,et al. Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. , 1993, The EMBO journal.
[108] S. Dhut,et al. Normal c-abl gene protein--a nuclear component. , 1991, Oncogene.
[109] G. Stamatoyannopoulos,et al. Rapid increase in red blood cell density driven by K:Cl cotransport in a subset of sickle cell anemia reticulocytes and discocytes. , 1991, Blood.
[110] E. Rubin,et al. Hypoxia-induced in vivo sickling of transgenic mouse red cells. , 1991, The Journal of clinical investigation.
[111] C. Enwonwu,et al. Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine. , 1990, The American journal of the medical sciences.
[112] C. Fletcher,et al. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. , 1990, The American journal of surgical pathology.
[113] S. Pileri,et al. Lymphohistiocytic T‐cell lymphoma (anaplastic large cell lymphoma CD30+/Ki‐1 + with a high content of reactive histiocytes) , 1990, Histopathology.
[114] R. Warnke,et al. CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35 , 1990, British journal of haematology.
[115] R. Larson,et al. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. , 1989, Leukemia.
[116] D. Baltimore,et al. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.
[117] M. Sasaki,et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. , 1989, Blood.
[118] G. Grosveld,et al. Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia , 1989, The Journal of experimental medicine.
[119] S. Mitani,et al. Expression of c‐myc Oncogens Product and ras Family Oncogene Products in Various Human Malignant Lymphomas Defined by Immunohistochemical Techniques , 1988, Cancer.
[120] M. Horton,et al. Identification of two normal bcr gene products in the cytoplasm. , 1988, Oncogene.
[121] R. Nagel,et al. Dense cells in sickle cell anemia: the effects of gene interaction. , 1984, Blood.
[122] R. Ochs,et al. Localization of nucleolar phosphoproteins B23 and C23 during mitosis. , 1983, Experimental cell research.
[123] A. Zelenetz,et al. Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation , 2002 .
[124] T. Manabe,et al. Bone marrow involvement in NPM-ALK-positive lymphoma: report of two cases. , 1999, Pathology, research and practice.
[125] M. Kadin,et al. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. , 1999, American journal of clinical pathology.
[126] A. Dejean,et al. Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.
[127] A. Dejean,et al. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells. , 1998, Blood.
[128] M. Kadin. Anaplastic large cell lymphoma and its morphological variants. , 1997, Cancer surveys.
[129] K. Papadopoulos,et al. Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. , 1997, Blood.
[130] M. Ladanyi. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. , 1997, Cancer surveys.
[131] J. Shuster,et al. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[132] A. Bernheim,et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. , 1996, Blood.
[133] B. Zehnbauer,et al. BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. , 1993, Blood.
[134] M. Groudine,et al. Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.
[135] L. Skow,et al. A mouse model for beta-thalassemia. , 1983, Cell.
[136] R. Nagel,et al. High expression of human 8s- and a-globins in transgenic mice: Erythrocyte abnormalities, organ damage, and the effect of hypoxia , 2022 .